As we conclude this year, we would like to thank the many individuals and organizations who have supported our work: the advocates like you; dozens of stakeholder groups; our 2023 Annual Sponsors, ImpediMed and the National Lymphedema Network; and our long-time Industry Partners, L&R USA, Jobst/Essity, and mediUSA.. 

Together, we are changing the landscape of lymphedema care in the United States, and we will continue to do everything possible to ensure that lymphedema patients have access to the treatments they need. Every person’s, group’s, and company’s involvement has been integral to our success, and we hope that you will remain engaged in 2024.

A new era for lymphedema coverage begins tomorrow! Thank you for your past, present, and future support, and we wish you and your loved ones a happy and healthy new year! 

Heather Ferguson
Founder & Executive Director
Lymphedema Advocacy Group

LymphedemaTreatmentAct.org



Below is a summary of the LTA final rule.
You can read the full 65 pages here. We have also inserted notes into our group’s public comment document, which can be read here, to indicate which of our comments were incorporated into the final rule.

The final rule is a huge victory for patients, but our work is not done yet. Please visit our Take Action page if you have any insurance plan other than traditional Medicare and haven’t contacted your own insurance provider yet. 
 

Lymphedema Treatment Act Final Rule Coverage Summary

What will be covered:

Frequency allowances:

Coverage requirements:

Codes and reimbursement rates:

Deductibles and copay:

PLEASE NOTE: The final rule also outlines the process for making future changes to and/or additions to coverage if/when needed. This is very important, and ensures we will not be in the position of needing to get another law passed if adjustments to the coverage need to be made, or if new treatment supplies become available and need to be added to coverage.

Together, our advocacy made all of this possible!